Affinity Asset Advisors’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $23.5M | Hold |
1,400,000
| – | – | 3.2% | 11 |
|
|
2025
Q1 | $21.5M | Hold |
1,400,000
| – | – | 2.05% | 9 |
|
|
2024
Q4 | $30.9M | Hold |
1,400,000
| – | – | 4.14% | 5 |
|
|
2024
Q3 | $25.2M | Sell |
1,400,000
-50,000
| -3% | -$901K | 3.44% | 6 |
|
|
2024
Q2 | $23.6M | Buy |
1,450,000
+50,000
| +4% | +$813K | 2.72% | 5 |
|
|
2024
Q1 | $19.8M | Sell |
1,400,000
-500,000
| -26% | -$7.06M | 2.45% | 10 |
|
|
2023
Q4 | $19.8M | Sell |
1,900,000
-100,000
| -5% | -$1.04M | 3.62% | 7 |
|
|
2023
Q3 | $20.4M | Buy |
2,000,000
+400,000
| +25% | +$4.08M | 5.74% | 2 |
|
|
2023
Q2 | $12M | Buy |
+1,600,000
| New | +$12M | 4.21% | 5 |
|